In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Liminatus Pharma Inc (NASDAQ: LIMN) closed at $5.09 down -14.17% from its previous closing price of $5.93. In other words, the price has decreased by -$14.17 from its previous closing price. On the day, 0.83 million shares were traded. LIMN stock price reached its highest trading level at $6.3075 during the session, while it also had its lowest trading level at $4.2.
Ratios:
For a deeper understanding of Liminatus Pharma Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.00 and its Current Ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LIMN now has a Market Capitalization of 137758816.
Stock Price History:
The Beta on a monthly basis for LIMN is 0.53, which has changed by -0.3669154 over the last 52 weeks, in comparison to a change of 0.20799685 over the same period for the S&P500. Over the past 52 weeks, LIMN has reached a high of $33.66, while it has fallen to a 52-week low of $4.40. The 50-Day Moving Average of the stock is -51.09%, while the 200-Day Moving Average is calculated to be -50.50%.
Shares Statistics:
For the past three months, LIMN has traded an average of 559.33K shares per day and 1710910 over the past ten days. A total of 26.01M shares are outstanding, with a floating share count of 11.87M. Insiders hold about 56.16% of the company’s shares, while institutions hold 0.46% stake in the company. Shares short for LIMN as of 1752537600 were 174194 with a Short Ratio of 0.36, compared to 1749772800 on 48268.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
